Today's Research Reports on Trending Tickers: Alnylam Pharmaceuticals and Endo International
NEW YORK, NY / ACCESSWIRE / July 19, 2018 / U.S. equities closed mostly higher Wednesday, as investors welcomed quarterly earnings and positive signs of a rapidly growing domestic economy. The Dow Jones Industrial Average gained 0.32 percent to close at 25,199.29, while the S&P 500 Index was up 0.22 percent to close at 2,815.62. The Nasdaq Composite Index declined 0.01 percent to close at 7,854.44.
Ken Winans, president of Winans Investments based in Novato, Calif. said, "It all still comes down to earnings and interest rates and so far we're good on earnings and we know from Jerome Powell, that the interest-rate picture is pretty predictable."
RDI Initiates Coverage on:
Alnylam Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=ALNY
Endo International plc
https://rdinvesting.com/news/?ticker=ENDP
Alnylam Pharmaceuticals' stock jumped 3.03% Wednesday, to close the day at $105.37. The stock recorded a trading volume of 555,393 shares, which was below its three months average volume of 756,855 shares. In the last year, Alnylam Pharmaceuticals' shares have traded in a range of 70.76 - 153.99. The share price has gained 48.91% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $102.03 is below its 200-day moving average of $112.81. Shares of Alnylam Pharmaceuticals have fallen roughly 0.81 percent in the past month and are down 17.06 percent year-to-date.
Access RDI's Alnylam Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ALNY
On Wednesday, shares of Endo International recorded a trading volume of 5,043,173 shares, which was below the three months average volume of 6,386,154 shares. The stock ended the day 3.51% higher at $11.21. The share price has fallen 10.61% from its 52 week high with a 52 week trading range of 5.27 - 12.52. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $9.02 is above its 200-day moving average of $7.16. Shares of Endo International have gained roughly 22.51 percent in the past month and are up 44.65 percent year-to-date.
Access RDI's Endo International plc Research Report at:
https://rdinvesting.com/news/?ticker=ENDP
Our Actionable Research on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Endo International plc (NASDAQ:ENDP) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
